Swedish Agency for Health Technology Assessment and Assessment of Social Services
News
-
Engelska nyheterCollaborationPublished: October 23, 2026
Interventions to strengthen foster family care
Certain interventions to strengthen foster family care may have positive effects for children in care. Promising results include improved mental health and attachment security, as well as reduced serious behavior problems, such as fewer days spent in locked units.
-
CollaborationPublished: October 23, 2026Systematic reviews play an increasingly important role in healthcare policy and governance
Health technology assessments are no longer limited to assessing specific interventions. Internationally, they are increasingly viewed as a strategic process for converting evidence into policy.
-
Health careNyheterPublikationPublished: October 23, 2026Evidence reports on post-COVID condition
These reports and evidence summaries have been produced by SBU as part of government assignments on post-COVID condition (long covid). The reports cover a variety of topics, such as physical exercise and other treatment and rehabilitation modalities, vaccination, and other issues relevant to the healthcare and support of individuals with post-COVID condition.
-
Om SBUPublished: September 1, 2026New training module for patient representatives in Sweden on the HTA regulation released
A new online training module on the HTA Regulation (HTAR) is now available. Developed by SBU in collaboration with EUPATI Sweden, it is primarily aimed at Swedish patient representatives who want to contribute to the HTAR process. HTAR is an EU regulation that enables joint assessments of new medicines and certain advanced medical devices across EU member states.
-
Engelska nyheterPublished: May 28, 2026Workplace harassment, and violence or threats and its associations with mental ill health
SBU has conducted an umbrella review based on 19 systematic reviews that were published between 2015 and 2025. These systematic reviews examined associations between workplace bullying, sexual harassment, or discrimination, as well as threats and violence, and mental ill health outcomes. The outcomes include symptoms of depression, anxiety, burnout, and PTSD.
-
Nytt uppdragPublished: October 23, 2025SBU receives its first EU-level clinical assessment assignment for a medicinal product
On the 20th of October 2025, SBU was assigned its first task as co-assessor within the EU collaboration for joint clinical assessments of medicinal products and medical devices. The assessment concerns a new medicinal product for the treatment of ovarian cancer and will be carried out together with Infarmed, the Portuguese authority for medicines and health products.